Recce Pharmaceuticals Ltd.ASX: RCE

Independent Review of Indonesian Phase 3 R327G Trial Data

· Issued by Recce Pharmaceuticals Ltd. via ASX

Filed with ASX ·

ASX Announcement Independent Data Monitoring Committee to Review Phase 3 Clinical Trial Data of Recce’s Topical Gel for Diabetic Foot Ulcer Infections Highlights: • Review of the blinded data indicates strong efficacy across the study population ® • RECCE 327 Gel (R327G) continues to...

View Attachment

6ix is reading this filing.

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases